Fundraising Fox
Aptatek
Princeton, US · 6 employees on LinkedIn · 1 known investors
Find your way into Aptatek
Sign up to see every warm intro you have to Aptatek
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aptatek team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.
Founders & leadership
MS
Milan StojanovicCo-Founder, Scientific Advisor
TW
Tilla WorgallCo-Founder, Medical Advisor
MB
Michael Boyce-Jacino, PhDCEO, President, Board of Directors
Investors · 1
In the news
Frequently asked questions
- What does Aptatek do?
- Aptatek BioSciences develops handheld, smartphone-based home monitoring tools for chronic disease patients, using a proprietary DNA aptamer assay to detect small-molecule biomarkers in real time. Its first product is an FDA Breakthrough Device-designated phenylketonuria (PKU) monitoring test that measures phenylalanine levels for at-home or point-of-care use.
- Who founded Aptatek?
- Aptatek was founded by Milan Stojanovic, Tilla Worgall.
- Who are Aptatek's investors?
- Aptatek's investors include Anzu Partners.
- Where is Aptatek headquartered?
- Aptatek is headquartered in Princeton, US.